Norsa Pharma sp. z o.o.

Manufacture of food supplements

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-01-26
Share capital
7,500.00 PLN
Activity description

Norsa Pharma is a Polish manufacturer that offers a wide range of specialized dietary supplements tailored to various health needs. Their product lineup includes items such as Omegasense Gold, Creatine Nucleo, and Vitamin D3+K2, among others. The company focuses on nutritional preparations to support health and well-being.

Registered address
ul. Mogilska 65, 31-545 Kraków, Poland
Opening hours
Mon–Fri, 9:00–17:00
Email
Social media

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 90 days late).

  • 202519/05/2026
  • 202409/04/2025
  • 202313/07/2024
  • 202213/07/2023
  • 202113/10/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 19%
Division · Manufacture of food products898 / 3,403
Top 26%
Sector · Manufacturing4,501 / 24,548
Top 18%
City · Kraków802 / 16,145
Top 5.0%
Voivodeship · Małopolskie1,733 / 27,724
Top 6.3%
Country · Poland20,853 / 297,069
Top 7.0%

Results vs industry

Revenue
This companyUSD 9.11mMedianUSD 284.01kAverageUSD 6.97m
Net profit
This companyUSD 3.02mMedianUSD 4.93kAverageUSD 683.78k
Operating costs
This companyUSD 5.32mMedianUSD 387.31kAverageUSD 6.05m
Assets
This companyUSD 4.33mMedianUSD 349.52kAverageUSD 6.87m

Offer

Websites

The sites are available in: Polish and English.

  • cystisorb.plCystisorb | żywność specjalnego przeznaczenia medycznego dla osób chorych na mukowiscydozę
    WordPress 5.7DiviApache
  • norsapharma.comSklep Norsa Pharma – suplementy diety i specjalistyczne preparaty żywieniowe, polski producent
    WooCommerceWordPress 7.1ElementorGoogle Tag ManagerRank MathApache
  • thyroset.plThyroset – zestaw witamin i minerałów przy niedoczynności tarczycy i Hashimoto
    Google Tag ManagerMeta PixelApache

Trademarks

The company holds 23 active trademarks registered with the Polish Patent Office. 2 applications are pending. 6 marks have expired or were not registered. The first mark was filed in 2015.

MarkNumberClassesStatusProtected until
iONA+ (word)Z.6018535Protected Apr 27, 2036
Duofibrin (word)Z.5979235Protected Feb 12, 2036
NORDIGAST (word)Z.5947615Protected Dec 3, 2035
CreatineNucleo (word)Z.5888735, 35Protected Aug 13, 2035
Omegasense (word)Z.58664429, 35Protected Jun 26, 2035
MarkProtected until
iONA+ (word)Apr 27, 2036
Duofibrin (word)Feb 12, 2036
NORDIGAST (word)Dec 3, 2035
CreatineNucleo (word)Aug 13, 2035
Omegasense (word)Jun 26, 2035

Authorized Representatives

Mateusz Łukasz Data age 43 – President of the Management Board

Manner of representation

In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
12$324.1516%
33$891.4144%
17$459.2122.6667%
8$216.1010.6667%
Arkadiusz Michalski
5$135.066.6666%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-02-13.

  • mBank
    54 1140 1049 0000 2773 4800 1002
  • mBank
    97 1140 1049 0000 2773 4800 1004
  • mBank
    81 1140 1049 0000 2773 4800 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

8 public aid cases recorded, with a total value of $708,549.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

European Funds

ProjectEU co-financing
Comprehensive treatment options for nutritional deficiencies in cystic fibrosis: bioavailability, efficacy, cost reduction.
$449.8K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Ekamedica sp. z o.o. + limited partnership
ALG Pharma sp. z o.o.
Nutropharma sp. z o.o.
Aura Herbals sp. z o.o.
Best Lab sp. z o.o.
Panawit sp. z o.o.
Intenson S.A.
Polamedica sp. z o.o.
BIO Herbs sp. z o.o.
Pharma Nord sp. z o.o.

Change history

DateEvent
2026-11-13Address change
2025-06-20Switch to PKD 2025
2020-02-20Share capital increase
2019-11-27Share capital increase
2018-06-11Address change

FAQ

Last updated: 2026-11-13